INS and Insulin resistance: Decreases elevated fasting serum glucose, postprandial serum glucose, TC, TG, LDL-C, and VLDL-C levels, increases the lowered serum insulin, liver glycogen, HDL-cholesterol, homeostasis model assessment-insulin resistance (HOMA-IS) and HOMA-β cell function, improves elevated cardiovascular risk indices